💭 Reflecting on a transformative 2023 at Juisci 🍋 🌟 This year, we've redefined how medical information is accessed and understood, from Juisci 2.0's breakthrough in scientific literature consumption to the launch of JuisciGPT. 👇 Learn more about our key milestones and the incredible journey towards a more informed and healthier society as we step into 2024 with gratitude and renewed commitment. #Healthcare #Innovation #Medical #Knowledge #Community #LookingAheadTo2024
About us
The amount of medical content is doubling every 73 days, with papers, studies and guidelines being published faster than any professional will ever be able to read. While processing relevant medical updates is crucial for all healthcare professionals, it has become complex, time & energy-consuming. Juisci simplifies medical content discovery, allowing professionals to better process, discuss and co-create content. We analyse content from thousands of sources, covering 20+ medical specialities and process them through our innovative AI technology to deliver reliable, updated and digestible information. Our award winning product is also available for healthcare organizations & life sciences companies looking for: -Boosting their content factory -Diffusing value-based content -Improving reach & engagement Medical breakthroughs are changing the landscape. Don’t get left behind. Stay updated with JUISCI.
- Website
-
http://www.juisci.com
External link for Juisci
- Industry
- IT Services and IT Consulting
- Company size
- 2-10 employees
- Type
- Privately Held
- Founded
- 2021
Employees at Juisci
-
David Luu, MD
Longevity Tech Entrepreneur | Heart Surgeon l Philanthropist. Founder: Hearty l Longevity Docs l The HeartFund l Juisci #StayYoung
-
Daniela Barros
Medical Operations Manager at Juisci || Medical & Scientific Writer
-
Graciela Rabadán
Medical Content Manager & Engagement Manager | PhD in Oncology-Hematology | ESCP Business School in Pharmaceutical Management-Marketing
-
olivier💻 maréchal
Freelance || solopreneur
Updates
-
🚀 Dive into AI in Non-Cardiac Vascular Arterial Diseases with Expert-Curated Content! 🤖🫀 We’re thrilled to introduce a new playlist on AI in Non-Cardiac Vascular Arterial Diseases, curated by our Lemon-Certified expert 🩺 Juliette RAFFORT-LAREYRE, M.D, Ph.D 🩺 📲 Explore this essential collection and stay ahead with the latest advancements: https://lnkd.in/emBSX9CH *********************************** If you want to showcase your expertise and stand out as a trusted expert, become Lemon Certified on Juisci! How? *Go to Settings in the Juisci app. *Click "Become Lemon Certified." *Upload your profile picture. *Submit your request! #AI #VascularDiseases #LemonCertified #Medical #Education #Continuous #Learning #Knowledge
-
-
Juisci reposted this
🤩 We’re on the brink of realizing my dream app product since launching Juisci! 🏝️ A lot has changed this summer at Juisci. Based on the invaluable feedback from our users, partners, and clients, I’m thrilled to announce that we’re launching Juisci 4.0 on September 17th! 🆕 What’s new? Juisci 4.0 introduces specialized in-app rooms that offer more in-depth content on the fields that matter most to you, alongside enhanced features to make staying up-to-date with the latest research faster and easier than ever before. 🍹 Think of it as more than just extra pulp in the juice—it’s a whole new blend. 🙏 Big thanks to the incredible Juisci Team 🍋, our accelerator Future4Care, our valued clients & partners and our amazing community for making this milestone possible. 📅 Stay tuned for more details, and mark your calendars for September 17th! #Science #AI #MedEd #Education #Innovation #Medical #Research #DigitalHealth #ContinuousLearning #MedTech
-
-
🚀 Breakthrough in Atopic Dermatitis Treatment with Nemolizumab 📊 A recent study in The Lancet highlights the significant potential of Nemolizumab, an IL-31 receptor antagonist, for treating moderate-to-severe atopic dermatitis. 🔬 In two phase 3 trials, Nemolizumab combined with topical therapies outperformed placebo, effectively reducing skin inflammation and itch. ⏱️ Rapid Results: By week 16, 36-38% of participants achieved nearly clear skin, with itch relief beginning as early as week 1. 🌟 Looking Ahead: If approved, Nemolizumab could revolutionize atopic dermatitis treatment, offering a powerful new option for patients. #Dermatology #MedicalResearch #ClinicalTrials #AtopicDermatitis #InnovationInHealthcare
-
-
🚀 Deep Dive into Simulation-Based Learning with Expert-Curated Content! 🧠 We’re excited to introduce a new playlist on Simulation-Based Learning, curated by our Lemon-Certified user 📚 Fouad MARHAR 📚. 📲 Explore this must-read collection and stay ahead with the latest insights: https://lnkd.in/erctvv-T *********************************** If you want to showcase your expertise and stand out as a trusted expert, become Lemon Certified on Juisci! How? *Go to Settings in the Juisci app. *Click "Become Lemon Certified." *Upload your profile picture. *Submit your request! #SimulationBasedLearning #LemonCertified #Medical #Education #Continuous #Learning #Knowledge
-
-
Juisci reposted this
Longevity Tech Entrepreneur | Heart Surgeon l Philanthropist. Founder: Hearty l Longevity Docs l The HeartFund l Juisci #StayYoung
Today, I had a meeting with a radiologist from Geneva. As we were wrapping up, he casually mentioned "and by the way, I wanted to thank you for building Juisci - I use it all the time." It's moments like these that remind me why we do what we do as entrepreneurs: creating something that genuinely helps people in their daily lives. ✊ Robin ROUMENGAS
-
🔬🧠 Exciting advancements in Alzheimer's disease diagnosis. 📊 A new JAMA study reveals that blood tests can significantly enhance the diagnostic accuracy of Alzheimer's disease in individuals with cognitive symptoms. 🚀 This groundbreaking research shows a 91% accuracy rate for detecting clinical Alzheimer's in both primary and secondary care settings. In contrast, standard clinical evaluations had an accuracy of only 61% in primary care and 73% in specialty care. 🩸 This research underscores the potential for blood tests to revolutionize Alzheimer's diagnosis in primary care, making early and accurate detection more accessible than ever before. 📲 Listen to the digest here: https://lnkd.in/eWHjajiU #Alzheimers #Research #Blood #Biomarkers #Early #Detection #Cognitive #Health
-
-
🚀🏅 The Paris Olympic Games are captivating audiences worldwide, highlighting not only athletic excellence but also the latest innovations in sports technology. As we witness these remarkable performances, let's understand the critical role of medical and technological advancements in athlete safety and performance enhancement. 🧬📚 At Juisci, we provide you with the most current medical research and insights on sports science and technology. 📲🔍 Explore our latest playlist on "AI Revolution: Transforming the Paris 2024 Olympic Games" on the Juisci app: https://lnkd.in/eQWn5FfR Dive into the science behind the games and elevate your sports knowledge! Ministère des Sports et des Jeux Olympiques et Paralympiques Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024 Comité International Olympique (CIO) #Paris2024 #Olympic #Innovation #Sports #Tech #AI #Athlete #Performance #Science #Medical #TechInSports #JuisciApp
-
As a healthcare professional, you’re already accustomed to scanning the conclusions of scientific publications to quickly determine their relevance 🔬 We've taken this practice to the next level with our "Slice of Science" videos 🎬🍋🍉🍓🥝 Here's what you can expect: 🎯 Start with the Conclusion: We dive right in by presenting the main insights and conclusions of the latest research, giving you the critical information upfront. 🔬 Background, Methodology, and Key Results: After the initial overview, we break down the background, methodology, and key results, ensuring you have a comprehensive overview of the study. Grab a slice now 🍓: https://lnkd.in/ejXiRzM4 #Healthcare #Medical #Research #Science #Updates #SliceOfScience #StayInformed #Videos
-
🔬 Scientists at Imperial College London, in collaboration with Duke-NUS Medical School in Singapore, have discovered that turning off the protein IL-11 can extend the healthy lifespan of mice by nearly 25%. 🚀 This groundbreaking study, published in Nature, involved deleting the IL-11 gene or treating older mice with an anti-IL-11 antibody, resulting in longer, healthier lives with fewer cancers and reduced aging symptoms. 📊 The findings reveal IL-11's role in promoting aging-related diseases like fibrosis and chronic inflammation. This research opens the door to potential treatments for aging in humans, offering hope for extended healthy lifespans. Clinical trials are needed to confirm the treatment's safety and effectiveness in humans. 📲 Listen to the digest here: https://lnkd.in/eRk_pibd #ScientificBreakthrough #AgingResearch #HealthyAging #MedicalResearch #Longevity #ImperialCollege #DukeNUS #NaturePublication
-